These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 18242457

  • 1. Fluoroquinolone therapy in a rabbit model of post-LASIK methicillin-resistant Staphylococcus aureus keratitis.
    Balzli CL, McCormick CC, Caballero AR, Huang B, Wigington L, Smith E, Tang A, O'Callaghan RJ.
    J Cataract Refract Surg; 2008 Feb; 34(2):295-301. PubMed ID: 18242457
    [Abstract] [Full Text] [Related]

  • 2. Penetration and effectiveness of prophylactic fluoroquinolones in experimental methicillin-sensitive or methicillin-resistant Staphylococcus aureus anterior chamber infections.
    Balzli CL, Caballero AR, Tang A, Weeks AC, O'Callaghan RJ.
    J Cataract Refract Surg; 2010 Dec; 36(12):2160-7. PubMed ID: 21111321
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of besifloxacin in a rabbit model of methicillin-resistant Staphylococcus aureus keratitis.
    Sanders ME, Norcross EW, Moore QC, Shafiee A, Marquart ME.
    Cornea; 2009 Oct; 28(9):1055-60. PubMed ID: 19724203
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of besifloxacin in an early treatment model of methicillin-resistant Staphylococcus aureus keratitis.
    Sanders ME, Moore QC, Norcross EW, Shafiee A, Marquart ME.
    J Ocul Pharmacol Ther; 2010 Apr; 26(2):193-8. PubMed ID: 20334537
    [Abstract] [Full Text] [Related]

  • 5. Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery.
    Moshirfar M, Mirzaian G, Feiz V, Kang PC.
    J Cataract Refract Surg; 2006 Mar; 32(3):515-8. PubMed ID: 16631067
    [Abstract] [Full Text] [Related]

  • 6. Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones.
    Callegan MC, Novosad BD, Ramadan RT, Wiskur B, Moyer AL.
    Adv Ther; 2009 Apr; 26(4):447-54. PubMed ID: 19381523
    [Abstract] [Full Text] [Related]

  • 7. Fluoroquinolone therapy in multiple-drug resistant staphylococcal keratitis after lamellar keratectomy in a rabbit model.
    Tungsiripat T, Sarayba MA, Kaufman MB, Sweet PM, Taban M, Carpenter TR, McDonnell PJ.
    Am J Ophthalmol; 2003 Jul; 136(1):76-81. PubMed ID: 12834673
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.
    Caballero AR, Marquart ME, O'Callaghan RJ, Thibodeaux BA, Johnston KH, Dajcs JJ.
    Curr Eye Res; 2006 Jan; 31(1):23-9. PubMed ID: 16421016
    [Abstract] [Full Text] [Related]

  • 9. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit.
    Dajcs JJ, Hume EB, Moreau JM, Caballero AR, Cannon BM, O'Callaghan RJ.
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1432-7. PubMed ID: 10798659
    [Abstract] [Full Text] [Related]

  • 10. Comparison of besifloxacin, gatifloxacin, and moxifloxacin against strains of pseudomonas aeruginosa with different quinolone susceptibility patterns in a rabbit model of keratitis.
    Sanders ME, Moore QC, Norcross EW, Sanfilippo CM, Hesje CK, Shafiee A, Marquart ME.
    Cornea; 2011 Jan; 30(1):83-90. PubMed ID: 20847656
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis.
    Dajcs JJ, Thibodeaux BA, Marquart ME, Girgis DO, Traidej M, O'Callaghan RJ.
    Antimicrob Agents Chemother; 2004 Jun; 48(6):1948-52. PubMed ID: 15155183
    [Abstract] [Full Text] [Related]

  • 12. Fourth-generation fluoroquinolone-resistant mycobacterial keratitis after laser in situ keratomileusis.
    Moshirfar M, Meyer JJ, Espandar L.
    J Cataract Refract Surg; 2007 Nov; 33(11):1978-81. PubMed ID: 17964409
    [Abstract] [Full Text] [Related]

  • 13. The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar (gatifloxacin 0.3%) in a NZW rabbit model.
    Romanowski EG, Mah FS, Yates KA, Kowalski RP, Gordon YJ.
    Am J Ophthalmol; 2005 May; 139(5):867-77. PubMed ID: 15860293
    [Abstract] [Full Text] [Related]

  • 14. Prophylactic gatifloxacin therapy in prevention of bacterial keratitis in a rabbit laser in situ keratomileusis model.
    Slade DS, Friday JW, Snyder RW, Nix DE, Kleinert LB, Patula VB.
    J Cataract Refract Surg; 2007 May; 33(5):888-92. PubMed ID: 17466866
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness of ciprofloxacin-polystyrene sulfonate (PSS), ciprofloxacin and ofloxacin in a Staphylococcus keratitis model.
    Moreau JM, Green LC, Engel LS, Hill JM, O'Callaghan RJ.
    Curr Eye Res; 1998 Aug; 17(8):808-12. PubMed ID: 9723996
    [Abstract] [Full Text] [Related]

  • 16. Methicillin-resistant Staphylococcus aureus infectious keratitis following refractive surgery.
    Solomon R, Donnenfeld ED, Perry HD, Rubinfeld RS, Ehrenhaus M, Wittpenn JR, Solomon KD, Manche EE, Moshirfar M, Matzkin DC, Mozayeni RM, Maloney RK.
    Am J Ophthalmol; 2007 Apr; 143(4):629-34. PubMed ID: 17320811
    [Abstract] [Full Text] [Related]

  • 17. Ciprofloxacin versus tobramycin for the treatment of staphylococcal keratitis.
    Callegan MC, Engel LS, Hill JM, O'Callaghan RJ.
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1033-7. PubMed ID: 8125714
    [Abstract] [Full Text] [Related]

  • 18. Comparative efficacy of topical moxifloxacin versus ciprofloxacin and vancomycin in the treatment of P. aeruginosa and ciprofloxacin-resistant MRSA keratitis in rabbits.
    Aliprandis E, Ciralsky J, Lai H, Herling I, Katz HR.
    Cornea; 2005 Mar; 24(2):201-5. PubMed ID: 15725889
    [Abstract] [Full Text] [Related]

  • 19. Zymar (Gatifloxacin 0.3%) shows excellent Gram-negative activity against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand White rabbit keratitis model.
    Mah FS, Romanowski EG, Kowalski RP, Yates KA, Gordon YJ.
    Cornea; 2007 Jun; 26(5):585-8. PubMed ID: 17525656
    [Abstract] [Full Text] [Related]

  • 20. Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model.
    Kowalski RP, Romanowski EG, Mah FS, Yates KA, Gordon YJ.
    Am J Ophthalmol; 2005 Sep; 140(3):497-504. PubMed ID: 16083841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.